-- TandAb platform enables reliable and rapid candidate selection -- Heidelberg, Germany, May 29, 2015 - Affimed N.V. (Nasdaq: AFMD), a clinical... ...http://newsr.in/n/Press+Releases/7551kzao3/Affimed-ASCO-Data-for-the-CD33-CD3-TandAb.htm
--Affimed's lead NK-cell engager AFM13 shows highly synergistic efficacy with PD-1 inhibitor-- Heidelberg, Germany, May 29, 2015 - Affimed N.V.... ...http://newsr.in/n/Press+Releases/7551kzao2/Affimed-ASCO-Data-Demonstrate-Consistent-Potency-of-NK.htm
Karan Jerath's innovation, a prototype novel device that could allow an undersea oil well to rapidly and safely recover in the event of a blowout,... ...http://social.yourstory.com/2015/05/indian-americans-intel-science-fair/
LONDON AstraZeneca and Eli Lilly are to combine two of their cancer drugs in a new clinical trial against solid tumors in the latest sign that such... ...http://in.reuters.com/article/2015/05/29/us-astrazeneca-eli-lilly-cancer-idINKBN0OE0HU20150529?feedType=RSS&feedName=health
Only a couple of months are left for the Steele County Relay for Life Committee's largest event for the American Cancer Society. But meanwhile the... ...http://www.topnews.in/steele-county-relay-life-committee-organizing-two-events-ahead-relay-2401733
Published since 1997,...